Management of neurofibromatosis type 2

被引:0
|
作者
Vincent, C [1 ]
Angot, A [1 ]
Louis, E [1 ]
Lejeune, JP [1 ]
Vaneecloo, FM [1 ]
机构
[1] Ctr Hosp Reg & Univ Lille, Hop R Salengro, Serv Otol & Otoneurol, F-59037 Lille, France
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Neurofibromatosis type 2 (NF2) is characterized by bilateral eighth cranial nerve schwannomas although some patients may have also other spinal and intracranial tumors. The disease has an autosomal-dominant mode of inheritance. The relationships between the heterogeneity within the NF2 gene mutations and the severity of the phenotype are not yet perfectly defined. The aim of the study is to report on our series of 13 patients with NF2 managed by our two departments in close collaboration. Treatment options have included observation, surgical intervention for complete tumor removal: middle fossa approach, retrosigmoid approach, combined middle fossa and retrosigmoid approach, translabyrinthine approach and translabyrinthine approach with auditory brainstem implantation.
引用
收藏
页码:727 / 731
页数:3
相关论文
共 50 条
  • [1] Management strategies in neurofibromatosis type 2
    Moffat, DA
    Quaranta, N
    Baguley, DM
    Hardy, DG
    Chang, P
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2003, 260 (01) : 12 - 18
  • [2] Pathogenesis and management of type 2 neurofibromatosis
    McCabe, Martin G.
    Evans, Dafydd Gareth
    EXPERT OPINION ON ORPHAN DRUGS, 2015, 3 (03): : 281 - 292
  • [3] Management strategies in neurofibromatosis type 2
    David Moffat
    Nicola Quaranta
    David Baguley
    David Hardy
    Phillip Chang
    European Archives of Oto-Rhino-Laryngology, 2003, 260 : 12 - 18
  • [4] Management of Neurofibromatosis Type 2 Associated Vestibular Schwannomas
    Jia, Huan
    Lahlou, Ghizlene
    Wu, Hao
    Sterkers, Olivier
    Kalamarides, Michel
    CURRENT OTORHINOLARYNGOLOGY REPORTS, 2021, 9 (02) : 170 - 176
  • [5] Management of Neurofibromatosis Type 2 Associated Vestibular Schwannomas
    Huan Jia
    Ghizlene Lahlou
    Hao Wu
    Olivier Sterkers
    Michel Kalamarides
    Current Otorhinolaryngology Reports, 2021, 9 : 170 - 176
  • [6] Management of spinal tumors in neurofibromatosis type 2 patients
    Nowak, Arkadiusz
    Dziedzic, Tomasz
    Czernicki, Tomasz
    Kunert, Przemyslaw
    Marchel, Andrzej
    NEUROLOGIA I NEUROCHIRURGIA POLSKA, 2016, 50 (01) : 31 - 35
  • [7] Neurofibromatosis type 2: management strategies of vestibular schwannomas
    Naude, A. A.
    Walsh, R. McConn
    Rawluk, D.
    Javadpour, M.
    Walsh, K.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2015, 184 : S123 - S123
  • [8] Management of multiple tumors in neurofibromatosis type 2 patients
    Aboukais, R.
    Bonne, N-X
    Baroncini, M.
    Zairi, F.
    Schapira, S.
    Vincent, C.
    Lejeune, J-P
    NEUROCHIRURGIE, 2018, 64 (05) : 364 - 369
  • [9] Management Strategy of Vestibular Schwannoma in Neurofibromatosis Type 2
    Odat, Haitham Ahmad
    Piccirillo, Enrico
    Sequino, Giuliano
    Taibah, Abdelkader
    Sanna, Mario
    OTOLOGY & NEUROTOLOGY, 2011, 32 (07) : 1163 - 1170
  • [10] Surgical management of vestibular schwannomas secondary to type 2 neurofibromatosis
    Roche, PH
    Robitail, S
    Thomassin, JM
    Pellet, W
    Régis, J
    NEUROCHIRURGIE, 2004, 50 (2-3) : 367 - 376